EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review)

Yiwen Li, Penghui Yan, Ji Zhang, Binghui Wu, Min Li, Baoliang Bao

Molecular Medicine Reports · 2026

DOI: 10.3892/mmr.2026.14012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Yiwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Graduate Studies, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Aptamers, Nucleotide. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the leading causes of cancer‑related deaths. The high incidence rate and poor prognosis of CRC pose a serious threat to public health, and impose a notable social and economic burden. Therefore, improving the accuracy of the early diagnosis and treatment of CRC is of notable importance. Aptamers have substantial potential for tumor‑targeted diagnosis and treatment due to their unique advantages, such as high affinity, high specificity and programmability. In the diagnosis and treatment of CRC, aptamers can specifically target receptors on the surface of cancer cells and intervene in the development of CRC by inhibiting receptor activity. The present study reviews the current state of research on aptamers to provide a new scientific basis and methods for diagnosing and treating CRC. The relevant research achievements are organized based on the two major branches of diagnostic detection and targeted therapy to systematically assess the translational value of various CRC aptamers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAptamers, NucleotideHumansSELEX Aptamer TechniqueAnimalsBiomarkers, TumorMolecular Targeted Therapy

Stichwörter der Autor:innen

CRCaptamersdiagnosistreatment

Substanzen

Aptamers, NucleotideBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Graduate Studies, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R. China.
  • Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R. China.
  • School of Clinical Medicine, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010050, P.R. China.

Zitieren

APA

Li, Y., Yan, P., Zhang, J., Wu, B., Li, M., & Bao, B. (2026). Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.14012

Vancouver

Li Y, Yan P, Zhang J, Wu B, Li M, Bao B. Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review). Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.14012

BibTeX
@article{Li2026,
  author = {Li, Yiwen and Yan, Penghui and Zhang, Ji and Wu, Binghui and Li, Min and Bao, Baoliang},
  title = {Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  doi = {10.3892/mmr.2026.14012}
}
Kostenlos starten →